A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis

ConclusionsDaily long-term application of glycopyrronium tosylate for up to 48  weeks (double blind plus open label) was generally well tolerated and efficacy was maintained. No new safety signals emerged.Trial RegistryClinicaltrials.gov NCT02553798.
Source: American Journal of Clinical Dermatology - Category: Dermatology Source Type: research